Follow
Parastoo Mirzabeygi
Parastoo Mirzabeygi
Verified email at razi.tums.ac.ir
Title
Cited by
Cited by
Year
A review of potential suggested drugs for coronavirus disease (COVID-19) treatment
P Tarighi, S Eftekhari, M Chizari, M Sabernavaei, D Jafari, P Mirzabeigi
European Journal of Pharmacology 895, 173890, 2021
1402021
Topical metronidazole can reduce pain after surgery and pain on defecation in postoperative hemorrhoidectomy
S Ala, M Saeedi, F Eshghi, P Mirzabeygi
Diseases of the colon & rectum 51, 235-238, 2008
1102008
The effect of curcumin on some of traditional and non-traditional cardiovascular risk factors: a pilot randomized, double-blind, placebo-controlled trial
P Mirzabeigi, AH Mohammadpour, M Salarifar, K Gholami, ...
Iranian journal of pharmaceutical research: IJPR 14 (2), 479, 2015
812015
Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost
H Khalili, I Karimzadeh, P Mirzabeigi, S Dashti-Khavidaki
European journal of internal medicine 24 (3), 227-233, 2013
762013
Is oxytocin a therapeutic factor for ischemic heart disease?
PM Ali Mohammad Alizadeh
Peptides 45, 66–72, 2013
242013
Spectrophotometric determination of captopril with DTNB reagent in pharmaceutical formulation. Boll Chim Farm. ; (6):249-51.
AM Hosseinimehr SJ, Ebrahimi P, Hassani N, Mirzabeigi P
Boll Chim Farm 143 (6), 249-51, 2004
172004
Effects of sitagliptin as monotherapy and add-on to metformin on weight loss among overweight and obese patients with type 2 diabetes: A systematic review and meta-analysis
L Janani, H Bamehr, K Tanha, P Mirzabeigi, H Montazeri, P Tarighi
Drug Research 71 (09), 477-488, 2021
82021
A review of therapeutic antibodies in breast cancer
M Eini, N Zainodini, H Montazeri, P Mirzabeigi, P Tarighi
Journal of Pharmacy & Pharmaceutical Sciences 24, 363-380, 2021
42021
Anti-Acinetobacter Baumannii single-chain variable fragments provide therapeutic efficacy in an immunocompromised mouse pneumonia model
E Basardeh, S Piri-Gavgani, HR Moradi, M Azizi, P Mirzabeigi, F Nazari, ...
BMC microbiology 24 (1), 55, 2024
2024
In-vitro cytotoxic potential of aerial parts of Leutea avicennae Mozaff. in different Human cancer cell lines
M Sabernavaei, H Montazeri, P Mirzabeigi, P Sharafi-Badr, M Zamani, ...
Natural Product Research, 1-8, 2023
2023
Optimization of Xanthan Gum and Sorbitol Levels in the Mycophenolate Mofetil Powder for Oral Suspension
A Umrani, H Faghihi, Z Mohammadi, P Mirzabeigi, H Montazeri Ghods, ...
Journal of Guilan University of Medical Sciences 31 (4), 362-377, 2023
2023
Examining the Learning Styles of the International Students at the Faculty of Pharmacy in the International Campus of Iran University of Medical Sciences
SS Mirfazli, E Movhedkor, P Mirzabeigi, SA Ahmadi Teymourlouy
Educational Development of Judishapur 12 (1), 88-95, 2021
2021
Towards Future Indications of Therapeutic Utilization of Stem Cells: a Case Report of Application after Hypoxic Encephalopathy
A Najafi, M Mojtahedzadeh, N Mohebbi, P Mirzabeigi, L Chelkeba, ...
Iranian Journal of Public Health 44 (Supple 2), 82-87, 2015
2015
Non-traditional Cardiovascular Risk Factors: A Pilot Randomized, Double-blind, Placebo-controlled Trial
P Mirzabeigi, AH Mohammadpour, M Salarifar, K Gholami, ...
The system can't perform the operation now. Try again later.
Articles 1–14